Cover Image
市場調查報告書

醫藥用化學品 - 美國市場的實際成果與預測

Pharmaceutical Chemicals (US Market & Forecast)

出版商 Freedonia Group 商品編碼 333518
出版日期 內容資訊 英文 497 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
醫藥用化學品 - 美國市場的實際成果與預測 Pharmaceutical Chemicals (US Market & Forecast)
出版日期: 2015年06月25日 內容資訊: 英文 497 Pages
簡介

美國的醫藥用化學品需求預計今後以年率6.1%增加,2019年預計達到540億美元。其約3分之一為學名藥廠商為中心在商業市場上的銷售額,其他來自專門成藥廠商的轉包、受託生產金額所構成。

本報告以美國的醫藥用化學品市場為焦點,提供2004年、2009年、2014年的需求變遷驗證、2019年到2024年的各原料藥 (API) 及原料的預測、市場市場環境指標、產業結構、51家參與企業的市場佔有率及簡介主要彙整。

第1章 摘要整理

第2章 市場環境

  • 概要
  • 宏觀經濟係數
  • 人口動態模式
  • 醫療趨勢
    • 健康保險改革
    • 內科疾病
      • 急性疾病
      • 慢性疾病
    • 國民醫療費
      • 支出類別
      • 資金來源
    • 醫療提供機關
      • 醫院
      • 門診病人診療設施
      • 內科醫院
      • 專門護養設施
    • 患者行動
      • 院內行動
      • 門診病人行動
    • 外科手術
  • 醫藥品產業概要
    • 法規
    • 研究開發
    • 產品出貨數
      • 臨床群組
      • 流通階層
      • 商業性情形

第3章 醫藥品用化學品概要

  • 概要
  • 需求模式的轉變
  • 美國的貿易
  • 國際市場
  • 臨床群組
  • 商業市場需求
  • 轉包、受託生產
  • 處方藥用化學品
  • 成藥用化學品

第4章 中樞神經藥

  • 概要
  • 精神治療藥
  • 神經系統藥
  • 帕金森氏症治療藥
  • 類風濕性關節炎治療藥
  • 眼科用劑
  • 其他中樞神經系統藥

第5章 荷爾蒙及相關藥物

  • 概要
  • 抗癌劑
  • 抗糖尿病藥物
  • 荷爾蒙補充治療
  • 雙磷酸鹽 (骨吸收抑制) 治療及相關藥物
  • 荷爾蒙避孕藥
  • 其他荷爾蒙治療及相關藥物

第6章 心血管藥

  • 概要
  • 降膽固醇藥物
  • 抗血栓溶解藥
  • β- 阻斷劑
  • 鈣離子阻斷劑
  • ARB型降壓藥
  • 血管收縮素轉化酵素 (ACE) 抑制劑
  • 利尿劑
  • 其他心血管藥

第7章 抗感染藥

  • 概要
  • 抗病毒藥
  • 抗生素
  • 奎諾酮類抗生素(Quinolones)劑
  • 其他抗生素

第8章 營養劑

  • 概要
  • 藥用植物及相關材料
  • 營養素
  • 散裝礦物質
  • 散裝維他命

第9章 生技藥品

  • 概要
  • 疫苗
  • 血液製劑

第10章 呼吸系統藥

  • 概要
  • 支氣管擴張藥
  • 抗組織胺藥
  • 吸入皮質類固醇藥
  • 止咳藥
  • 其他呼吸系統藥

第11章 腸胃藥

  • 概要
  • 質子幫浦阻斷劑
  • 抗嘔吐藥
  • 便秘藥
  • 腸胃抗發炎藥
  • 市售抗酸藥
  • 止瀉藥
  • 其他腸胃藥

第12章 皮膚科藥

  • 概要
  • 乾癬治療藥
  • 皮膚科抗感染藥
  • 抗外因性疼痛藥
  • 抗粉刺藥
  • 其他皮膚科藥

第13章 其他的醫藥品用化學品

  • 概要
  • 生殖器、泌尿科藥
  • 其他所有醫藥品用化學品

第14章 產業結構

  • 概要
  • 市場佔有率
  • 競爭策略
  • M&A
  • 授權及相關合約
  • 行銷及流通
  • 製造
  • 企業簡介
目錄
Product Code: 3280

US demand to increase 6.1% annually through 2019

image1

US demand for pharmaceutical chemicals is forecast to rise 6.1 percent annually to $54 billion in 2019. Merchant market sales primarily to generic drug companies will account for nearly one-third of this total. The remainder of demand will consist of the value of pharmaceutical chemicals produced captively or contracted for internal use by makers of proprietary drugs.


New therapies to drive captive & contract market

Although moderated by patent losses, the value of pharmaceutical chemicals obtained from captive and contract production systems will sustain favorable growth, expanding 5.3 percent annually to $36.7 billion in 2019. The introduction of new therapies with enhanced efficacy will underlie gains. For example, in 2014, a total of 41 new molecular entities were approved for marketing by the Food and Drug Administration. Among these approvals were several breakthrough therapies, including blinatumomab for acute lymphoblastic leukemia, ceritinib for late-stage non-small cell lung cancer, ledipasvir/sofosbuvir for chronic hepatitis C, nintedanib and pirfenidone for idiopathic pulmonary fibrosis, and nivolumab for metastatic melanoma. In addition to new molecular entities, growth prospects for proprietary pharmaceutical chemicals will benefit from a number of recent prescription to over-thecounter switches, which extended commercial protection on non-prescription versions of compounds such as esomeprazole magnesium and fluticasone proprionate.

Merchant market demand to grow nearly 8% per annum

Based on the impact of recent and forthcoming drug patent expirations and the expansion of the generic drug industry, merchant market demand for pharmaceutical chemicals will increase 7.8 percent per year to $17.3 billion in 2019. Gains will reflect the introduction and rapid market penetration of generic versions of several blockbuster drugs. Among the pharmaceutical chemicals projected to generate impressive growth in merchant sales due to patent expirations are aripiprazole for bipolar disorder; capecitabine for metastatic breast and colorectal cancer; celecoxib for arthritis; duloxitine HCl for depression, generalized anxiety, and chronic pain; eszopiclone for insomnia; glatiramer acetate for multiple sclerosis; oxycodone HCl for pain management; and raloxifene HCl for osteoporosis.

Study coverage

This upcoming Freedonia industry study, Pharmaceutical Chemicals, presents historical demand data (2004, 2009, 2014) plus forecasts (2019, 2024) by type of active pharmaceutical ingredient (API) and raw material. The study also considers key market environment factors, assesses the industry structure, evaluates company market share, and profiles 51 participants in the US industry.

Table of Contents

INTRODUCTION

I. EXECUTIVE SUMMARY

II. MARKET ENVIRONMENT

  • General
  • Macroeconomic Factors
  • Demographic Patterns
  • Healthcare Trends
    • Health Insurance Reforms
    • Medical Conditions
      • Acute Conditions
      • Chronic Conditions
    • National Health Expenditures
      • Spending Categories
      • Funding Sources
    • Medical Providers
      • Hospitals
      • Outpatient Facilities
      • Physicians
      • Skilled Nursing Homes
    • Patient Activity
      • Hospital Activity
      • Outpatient Activity
    • Surgical Procedures
  • Pharmaceutical Industry Overview
    • Regulation
    • Research & Development
    • Product Shipments
      • Therapeutic Groups
      • Distribution Classes
      • Commercial Status

III. PHARMACEUTICAL CHEMICALS OVERVIEW

  • General
  • Historical Demand Patterns
  • US Trade
  • International Markets
  • Therapeutic Groups
  • Merchant Market Demand
  • Captive & Contract Production
  • Ethical Pharmaceutical Chemicals
  • Over-the-Counter Pharmaceutical Chemicals

IV. CENTRAL NERVOUS SYSTEM CHEMICALS

  • General
  • Psychotherapeutic Agents
    • Antipsychotic Agents
    • Antidepressants
    • Anti-Anxiety Agents
    • OTC Sedatives
  • Neurological Agents
    • Anticonvulsants
    • Multiple Sclerosis Treatments
    • Alzheimer's Disease Treatments
  • Parkinson's Disease Treatments
    • Other Neurological Agents
    • Pain Control Agents
    • Narcotic Analgesics
    • Over-the-Counter Analgesics
    • Ethical Nonsteroidal Anti-Inflammatory Agents
    • Antimigraine Agents
    • Anesthetics
    • Hyaluronic Acid
  • Rheumatoid Arthritis Treatment Chemicals
    • Monoclonal Antibodies
    • Other Arthritis Treatments
  • Ophthalmic Agents
    • Anti-Angiogenic Agents
    • Glaucoma Treatments
    • Other Ophthalmic Agents
  • Other Central Nervous System Chemicals
    • CNS Stimulants
    • Muscle Relaxants
    • Smoking Cessation Compounds
    • Anti-Obesity Agents

V. HORMONES & RELATED CHEMICALS

  • General
  • Anticancer Agents
    • Monoclonal Antibodies
    • Enzyme Inhibitors
    • Growth Factors
    • Immunomodulating Agents
    • Other Anticancer Agents
    • Selected Anticancer Agents in Development
  • Antidiabetic Agents
    • Insulins
    • DPP-4 Inhibitors
    • Biguanides
    • Thiazolidinediones
    • GLP-1 Agonists
    • Sulfonylureas
    • Other Antidiabetic Agents
  • Hormone Replacement Therapies
    • Thyroid Agents
    • Erythropoietins
    • Estrogens
    • Growth Hormones
    • Other Hormone & Related Replacement Therapies
  • Bisphosphonates & Related Agents
  • Hormonal Contraceptives
    • Combination Oral Contraceptives
    • Progestin-Only Pills
    • Other Hormonal Contraceptives
  • Other Hormones & Related Agents

VI. CARDIOVASCULAR CHEMICALS

  • General
  • Cholesterol Reducers
  • Antithrombolytic Agents
    • Patent Expirations
    • Marketed Products
  • Beta Blockers
  • Calcium Channel Blockers
  • Angiotensin II Receptor Antagonists
  • ACE Inhibitors
  • Diuretics
  • Other Cardiovascular Drugs
    • Alpha Adrenergic Agonists
    • Anti-Arrhythmics
    • Bradykinin B2 Receptor Antagonists
    • Cardiac Glycosides
    • Endothelin Receptor Antagonists
    • Vasodilators
    • All Other Cardiovascular Drugs

VII. ANTI-INFECTIVE CHEMICALS

  • General
  • Antiviral Agents
    • Hepatitis Antiviral Agents
    • HIV Antiviral Agents
    • Other Antiviral Agents
  • Antibiotics
    • Penicillins
    • Macrolides
    • Cephalosporins
  • Quinolones
  • Other Antibiotics
    • Oral Antiseptics
    • Other Anti-Infective Agents
    • Antifungal Agents
    • Antimalarial Agents

VIII. NUTRITIONAL CHEMICALS

  • General
  • Herbal & Related Ingredients
    • Herbal & Botanical Extracts
    • Fish Oils
    • Marine & Related Extracts
  • Nutrients
    • Proteins
    • Fibers
    • Probiotics
    • Other Nutrients
  • Bulk Minerals
    • Electrolytes
    • Essential Minerals
    • Trace Minerals
  • Bulk Vitamins
    • Vitamin C
    • Vitamin A
    • B-Group Vitamins
    • Vitamin E
    • Other Vitamins

IX. BIOLOGICAL CHEMICALS

  • General
  • Vaccines
    • Attenuated Vaccines
    • Conjugate Vaccines
    • Inactivated Vaccines
    • Recombinant Vaccines
    • Toxoid Vaccines
    • Vaccines in Development
  • Blood Derivatives
    • Plasma Protein Therapies
    • Cellular Components
    • Other Blood-Related Chemicals

X. RESPIRATORY CHEMICALS

  • General
  • Bronchodilators
  • Antihistamines
  • Inhaled Corticosteroids
  • Antitussives
  • Other Respiratory Chemicals
    • Decongestants
    • Expectorants & Mucolytics
    • Omalizumab
    • Leukotriene Receptor Antagonists (LRAs)
    • Selective Phosphodiesterase-4 Inhibitors
    • Ivacaftor
    • Nintedanib
    • Pirfenidone
    • Surfactants

XI. GASTROINTESTINAL CHEMICALS

  • General
  • Proton Pump Inhibitors
  • Anti-Emetic Agents
  • Laxatives
  • Gastrointestinal Anti-Inflammatory Agents
  • OTC Antacids
  • Antidiarrheals
  • Other Gastrointestinal Agents

XII. DERMATOLOGICAL CHEMICALS

  • General
  • Antipsoriatic Agents
  • Dermatological Anti-Infective Agents
    • Antibacterial Compounds
    • Antifungal Compounds
    • Other Dermatological Anti-Infective Compounds
  • External Analgesics
  • Anti-Acne Agents
  • Other Dermatological Chemicals

XIII. OTHER PHARMACEUTICAL CHEMICALS

  • General
  • Genito-Urinary Chemicals
    • Erectile Dysfunction (ED) Treatments
    • Benign Prostate Hyperplasia (BPH) Treatments
    • Overactive Bladder Treatments
  • All Other Pharmaceutical Chemicals
    • Antitransplant Rejection Agents
    • Chelating Agents

XIV. INDUSTRY STRUCTURE

  • General
  • Market Share
  • Competitive Strategies
  • Mergers & Acquisitions
  • Licensing & Related Agreements
  • Marketing & Distribution
  • Manufacturing

Company Profiles

  • Aceto Corporation
  • Ajinomoto Company Incorporated
  • Albemarle Corporation
  • Althea Technologies, see Ajinomoto
  • American Pacific Corporation
  • Aptuit LLC
  • Aurobindo Pharma Limited
  • BASF SE
  • Biocon Limited
  • Cambrex Corporation
  • Carbogen Amcis, see Dishman Pharmaceuticals and Chemicals
  • Cipla Limited
  • Daiichi Fine Chemical, see Kyowa Hakko Kirin
  • Daiichi Sankyo Company Limited
  • Dishman Pharmaceuticals and Chemicals Limited
  • DPx Holdings, see Royal DSM
  • Dr. Reddy's Laboratories Limited
  • DSM Sinochem Pharmaceuticals, see Royal DSM
  • Epax, see FMC
  • Fabbrica Italiana Sintetici SpA
  • FMC Corporation
  • FUJIFILM Holdings Corporation
  • Johnson & Johnson
  • Johnson Matthey plc
  • Kyowa Hakko Kirin Company Limited
  • Lonza Group Limited
  • Lupin Limited
  • Macfarlan Smith, see Johnson Matthey
  • Mallinckrodt plc
  • Noramco, see Johnson & Johnson
  • Novartis AG
  • Novasep Holding SAS
  • Pfanstiehl Incorporated
  • PHF, see Fabbrica Italiana Sintetici
  • Ranbaxy Laboratories, see Sun Pharmaceutical Industries
  • Royal DSM NV
  • Shanghai SynTheAll Pharmaceutical, see WuXi PharmaTech Cayman
  • SI Group Incorporated
  • Sigma-Aldrich Corporation
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Limited
  • WuXi PharmaTech Cayman Incorporated
  • Additional Companies in the Pharmaceutical Chemicals Industry

LIST OF TABLES

SECTION I -- EXECUTIVE SUMMARY

  • Summary Table

SECTION II -- MARKET ENVIRONMENT

  • 1 Macroeconomic Indicators
  • 2 Resident Population by Age Group
  • 3 Health Insurance Coverage of the US Population, 2004-2014
  • 4 Acute Conditions by Type
  • 5 Chronic Conditions by Type
  • 6 National Health Expenditures by Spending Category
  • 7 National Health Expenditures by Funding Source
  • 8 Medical Providers
  • 9 Patient Activity
  • 10 Pharmaceutical Shipments by Therapeutic Group
  • 11 Pharmaceutical Shipments by Distribution Status
  • 12 Pharmaceutical Shipments by Commercial Status

SECTION III -- PHARMACEUTICAL CHEMICALS OVERVIEW

  • 1 Pharmaceutical Chemicals Demand, 2004-2014
  • 2 US Trade in Pharmaceutical Chemicals
  • 3 World Pharmaceutical Chemicals Merchant Demand
  • 4 Pharmaceutical Chemicals Demand by Therapeutic Group
  • 5 Pharmaceutical Chemicals: Merchant Market Demand by Therapeutic Group
  • 6 Pharmaceutical Chemicals: Captive & Contract Production Output
  • 7 Pharmaceutical Chemicals: Ethical Pharmaceuticals Demand
  • 8 Pharmaceutical Chemicals: Over-the-Counter Pharmaceuticals Demand

SECTION IV -- CENTRAL NERVOUS SYSTEM CHEMICALS

  • 1 Central Nervous System (CNS) Chemicals Demand
  • 2 Psychotherapeutic Chemicals Demand
  • 3 Neurological Chemicals Demand
  • 4 Pain Control Chemicals Demand
  • 5 Rheumatoid Arthritis Treatment Chemicals Demand by Source of Supply
  • 6 Ophthalmic Chemicals Demand
  • 7 Other Central Nervous System Chemicals Demand

SECTION V -- HORMONES & RELATED CHEMICALS

  • 1 Hormones & Related Chemicals Demand
  • 2 Anticancer Chemicals Demand
  • 3 Antidiabetic Chemicals Demand
  • 4 Hormone Replacement Chemicals Demand
  • 5 Bisphosphonates & Related Chemicals Demand by Source of Supply
  • 6 Hormonal Contraceptive Chemicals Demand by Source of Supply
  • 7 Other Hormones & Related Chemicals Demand by Source of Supply

SECTION VI -- CARDIOVASCULAR CHEMICALS

  • 1 Cardiovascular Chemicals Demand
  • 2 Cholesterol-Reducing Chemicals Demand by Source of Supply
  • 3 Antithrombolytic Chemicals Demand by Source of Supply
  • 4 Beta Blocker Chemicals Demand by Source of Supply
  • 5 Calcium Channel Blocker Chemicals Demand by Source of Supply
  • 6 Angiotensin II Antagonist Chemicals Demand by Source of Supply
  • 7 ACE Inhibitor Chemicals Demand by Source of Supply
  • 8 Diuretic Chemicals Demand by Source of Supply
  • 9 Other Cardiovascular Chemicals Demand by Source of Supply

SECTION VII -- ANTI-INFECTIVE CHEMICALS

  • 1 Anti-Infective Chemicals Demand
  • 2 Antiviral Chemicals Demand
  • 3 Antibiotic Chemicals Demand
  • 4 Oral Antiseptics Chemicals Demand by Source of Supply
  • 5 Other Anti-Infective Chemicals Demand

SECTION VIII -- NUTRITIONAL CHEMICALS

  • 1 Nutritional Chemicals Demand
  • 2 Herbal & Related Chemicals Demand
  • 3 Nutrient Chemicals Demand
  • 4 Bulk Minerals Demand
  • 5 Bulk Vitamins Demand

SECTION IX -- BIOLOGICAL CHEMICALS

  • 1 Biological Chemicals Demand
  • 2 Vaccine Chemicals Demand by Source of Supply
  • 3 Blood Derivative Chemicals Demand by Source of Supply

SECTION X -- RESPIRATORY CHEMICALS

  • 1 Respiratory Chemicals Demand
  • 2 Bronchodilator Chemicals Demand by Source of Supply
  • 3 Antihistamine Chemicals Demand
  • 4 Corticosteroid Chemicals Demand
  • 5 Antitussive Chemicals Demand
  • 6 Other Respiratory Chemicals Demand

SECTION XI -- GASTROINTESTINAL CHEMICALS

  • 1 Gastrointestinal Chemicals Demand
  • 2 Proton Pump Inhibitors Chemicals Demand
  • 3 Anti-Emetic Chemicals Demand by Source of Supply
  • 4 OTC Laxative Chemicals Demand
  • 5 Gastrointestinal Anti-Inflammatory Chemicals Demand by Source of Supply
  • 6 OTC Antacid Chemicals Demand
  • 7 Antidiarrheal Chemicals Demand
  • 8 Other Gastrointestinal Chemicals Demand by Source of Supply

SECTION XII -- DERMATOLOGICAL CHEMICALS

  • 1 Dermatological Chemicals Demand
  • 2 Antipsoriatic Chemicals Demand
  • 3 Dermatological Anti-Infective Chemicals Demand
  • 4 External Analgesic Chemicals Demand
  • 5 Anti-Acne Chemicals Demand
  • 6 Other Dermatological Chemicals Demand

SECTION XIII -- OTHER PHARMACEUTICAL CHEMICALS

  • 1 Other Pharmaceutical Chemicals Demand
  • 2 Genito-Urinary Chemicals Demand
  • 3 All Other Pharmaceutical Chemicals Demand

SECTION XIV -- INDUSTRY STRUCTURE

  • 1 Pharmaceutical Chemicals: US Merchant Sales by Company, 2014
  • 2 Selected Acquisitions & Divestitures
  • 3 Selected Cooperative Agreements

LIST OF CHARTS

SECTION II -- MARKET ENVIRONMENT

  • 1 Pharmaceutical Shipments by Therapeutic Group, 2019

SECTION III -- PHARMACEUTICAL CHEMICALS OVERVIEW

  • 1 Pharmaceutical Chemicals Demand by Therapeutic Group, 2019

SECTION IV -- CENTRAL NERVOUS SYSTEM CHEMICALS

  • 1 Central Nervous System Chemicals Demand by Type, 2019

SECTION V -- HORMONES & RELATED CHEMICALS

  • 1 Hormones & Related Chemicals Demand by Type, 2019

SECTION VI -- CARDIOVASCULAR CHEMICALS

  • 1 Cardiovascular Chemicals Demand by Type, 2019

SECTION VII -- ANTI-INFECTIVE CHEMICALS

  • 1 Anti-Infective Chemicals Demand by Type, 2019

SECTION VIII -- NUTRITIONAL CHEMICALS

  • 1 Nutritional Chemicals Demand by Type, 2019

SECTION X -- RESPIRATORY CHEMICALS

  • 1 Respiratory Chemicals Demand by Type, 2019

SECTION XI -- GASTROINTESTINAL CHEMICALS

  • 1 Gastrointestinal Chemicals Demand by Type, 2019

SECTION XII -- DERMATOLOGICAL CHEMICALS

  • 1 Dermatological Chemicals Demand by Type, 2019

SECTION XIV -- INDUSTRY STRUCTURE

  • 1 Pharmaceutical Chemicals: US Merchant Market Share, 2014
Back to Top